GSK’s RSV vaccine ‘Arexvy’ receives positive European Medicines Agency’s CHMP opinion for adults aged 50-59
Decision on EU marketing authorisation for this population expected by September 2024
Decision on EU marketing authorisation for this population expected by September 2024
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Renews GMP certifications for India and Malaysia sites
Subscribe To Our Newsletter & Stay Updated